Previous 10 | Next 10 |
The more things change, the more I guess they stay the same. After a sharp drop in the wake of its worst quarterly report in years, and growing investor concern about the direction and fundamental growth capacity of the business, 3M ( MMM ) has chosen to spend almost $7 billion of shareholde...
The following slide deck was published by Smith & Nephew plc in conjunction with their 2019 Q1 earnings Read more ...
Smith & Nephew PLC (SNN) Q1 2019 Earnings Conference Call May 02, 2019, 03:30 ET Company Participants Namal Nawana - CEO & Executive Director Bradley Cannon - President of Sports Medicine & ENT Graham Baker - CFO & Executive Director Conference Call Participant...
Quick Take KCI Holdings ( KCIH ) has filed to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement . Prior to completion of the offering, KCI will become the holding company of the business conducted by Acelity and its subsidiaries - Kinetic Con...
Investment Thesis While Osiris Therapeutics (OSIR) has appreciated 40% during the calendar year 2019, it is still significantly undervalued. The company's sales growth and earnings growth have been accelerating due to OSIR's increasing market success with its impactful suite of medical solut...
I have been researching Osiris Therapeutics (NASDAQ: OSIR) for several years. Last year I began summarizing my perspective in articles on Seeking Alpha. My most recent blog post was September 2018. I did this to fill the void left by a lack of public analyst coverage. While I have been the...
In the long run, it's not just how much money you make that will determine your future prosperity. It's how much of that money you put to work by saving it and investing it. - Peter Lynch (stellar value and growth investor) On March 12, 2019, Osiris Therapeutics ( OSIR ) disclosed that S...
LONDON , March 12, 2019 /PRNewswire/ -- Brainlab, the global pioneer of software-driven medical technology, and Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business, announce that Smith & Nephew has agreed to acquire the Brainlab orthopaedic joint ...
LONDON , March 12, 2019 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology company, today announces product launches and investments that establish its multi-asset digital surgery and robotic ecosystem. Namal Nawana, Chief Executive Officer...
LONDON , March 12, 2019 /PRNewswire/ -- Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, announces that it has agreed to acquire Osiris Therapeutics, Inc. (NASDAQ: OSIR), a fast growing company delivering regenerative medicine products, including ...
News, Short Squeeze, Breakout and More Instantly...
Smith & Nephew SNATS Inc. Company Name:
SNN Stock Symbol:
NYSE Market:
Smith & Nephew SNATS Inc. Website:
Engineered for precision, confidence and efficiency in surgery - and compatible with the CORI ◊ Surgical System Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance for its new CATALYSTEM Primary Hip System fro...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company announces its Orthopaedics for All initiative – a global advisory board established to amplify diversity by building equity, breaking biases, and inspiring inclusion for individuals wishing to pursue a career in ort...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will sponsor tennis players participating in The Championships, Wimbledon 2024 to spotlight its advanced Sports Medicine portfolio alongside some of the greatest athletes in the world. Smith+Nephew endeavou...